These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation. Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D Am J Nephrol; 1999; 19(6):634-40. PubMed ID: 10592356 [TBL] [Abstract][Full Text] [Related]
5. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection. Patschan D; Kribben A; Pietruck F; Lutz J; Binek M; Philipp T; Heemann U; Witzke O Nephron Clin Pract; 2006; 103(3):c94-9. PubMed ID: 16534238 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection. Kamath S; Dean D; Peddi VR; Schroeder TJ; Alexander JW; Cavallo T; First MR Transplantation; 1997 Nov; 64(10):1428-32. PubMed ID: 9392306 [TBL] [Abstract][Full Text] [Related]
7. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection. Woodle ES; Bruce DS; Josephson M; Cronin D; Newell KA; Millis JM; Piper JB; O'Laughlin R; Thistlethwaite JR Clin Transplant; 1996 Aug; 10(4):389-95. PubMed ID: 8884115 [TBL] [Abstract][Full Text] [Related]
8. OKT3 for the treatment of steroid-resistant acute renal allograft rejection. Jogose JT; Bailey RR; Lynn KL; Robson RA; Wells JE Nephron; 1997; 77(3):298-303. PubMed ID: 9375823 [TBL] [Abstract][Full Text] [Related]
9. Effect of OKT3 in steroid-resistant renal transplant rejection. Petrie JJ; Rigby RJ; Hawley CM; Suranyi MG; Whitby M; Wall D; Hardie IR Transplantation; 1995 Feb; 59(3):347-52. PubMed ID: 7871563 [TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of rejection after simultaneous pancreas-kidney transplantation. Yang L; Liu YF; Liu SR; Wu G; Zhang JL; Meng YM; Shong SW; Li GC Chin Med Sci J; 2005 Sep; 20(3):210-3. PubMed ID: 16261897 [TBL] [Abstract][Full Text] [Related]
11. Time course of response to pulse methylprednisolone therapy in renal transplant recipients with acute allograft rejection. Shinn C; Malhotra D; Chan L; Cosby RL; Shapiro JI Am J Kidney Dis; 1999 Aug; 34(2):304-7. PubMed ID: 10430978 [TBL] [Abstract][Full Text] [Related]
12. Sialyl Lewis(x) (CD15s) monitoring as a means to select antirejection therapy in patients with rejection after renal transplantation: CD15s monitoring for treatment and diagnosis in patients with acute rejection after renal transplantation. Ishida H; Koyama I; Sawada T; Murakami T; Tojimbara T; Nakajima I; Tanabe K; Yamaguchi Y; Fuchinoue S; Toma H; Agishi T Transplantation; 2000 May; 69(10):2208-11. PubMed ID: 10852628 [TBL] [Abstract][Full Text] [Related]
14. Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection. Herget S; Heemann U; Friedrich J; Kribben A; Wagner K; Philipp T Clin Nephrol; 1996 May; 45(5):352-4. PubMed ID: 8738671 [TBL] [Abstract][Full Text] [Related]
15. [Radiotherapy within the scope of allogeneic kidney transplantation: an indication for local irradiation?]. Micke O; Seegenschmiedt MH; Bruns F; Matzkies FK; Schäfer U; Willich N Strahlenther Onkol; 2002 May; 178(5):280-5. PubMed ID: 12082689 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation. Shennib H; Massard G; Reynaud M; Noirclerc M J Heart Lung Transplant; 1994; 13(3):514-9. PubMed ID: 8061029 [TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients. Kumano K; Irie A; Mashimo S; Endo T; Koshiba K Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691 [No Abstract] [Full Text] [Related]
18. [OKT3 treatment of refractory renal allograft rejection]. Xu J; Ma J; Bai X Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):223-5. PubMed ID: 10374543 [TBL] [Abstract][Full Text] [Related]
19. OKT3 serum levels as a guide for prophylactic therapy: a pilot study in kidney transplant recipients. Abramowicz D; Goldman M; Mat O; Estermans G; Crusiaux A; Vanherweghem JL; De Pauw L; Kinnaert P; Vereerstraeten P Transpl Int; 1994 Jul; 7(4):258-63. PubMed ID: 7916925 [TBL] [Abstract][Full Text] [Related]